Windlas Biotech announces ₹47 Cr buyback of 4.7 lakh shares at ₹1,000/share

Windlas Biotech Limited has announced a buyback offer for up to 4,70,000 fully paid-up equity shares, each with a face value of ₹5. The buyback price is set at ₹1,000 per equity share, payable in cash, totaling an aggregate maximum amount not exceeding ₹47,00,00,000 (₹47 Crore), excluding transaction costs. This represents 2.23% of the company's existing total paid-up equity share capital. The buyback will be conducted through the 'Tender Offer' route on a proportionate basis. The Record Date for eligible shareholders is Friday, April 24, 2026. The Letter of Offer, dated April 27, 2026, is being dispatched to eligible shareholders by April 28, 2026. The offer size represents 9.80% of the aggregate of total paid-up share capital and free reserves, based on March 31, 2025 financials, adhering to the statutory limit.